Skip to content

Comparative study on the timing of laser hair removal for expanded scalp and facial flaps: efficacy analysis during the expansion period versus after flap transfer

Comparative study on the timing of laser hair removal for expanded scalp and facial flaps: efficacy analysis during the expansion period versus after flap transfer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125550
Enrollment
Unknown
Registered
2026-05-28
Start date
2026-05-31
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hair removal for expanded flap

Interventions

Expander hair removal group (Group A):None
Post-expansion flap hair removal group (Group B):None

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients requiring implantation of skin and soft tissue expanders in the head and face region due to various reasons (e.g., scars, alopecia, post-tumor resection reconstruction, organ reconstruction, etc.); 2. Patients who have received at least one session of laser hair removal on the expanded area either during the expander inflation period or after completion of expander inflation (target volume achieved) and following expander removal with flap transfer surgery; 3. Patients with clear and complete medical records (including documentation of expander inflation, laser hair removal sessions, and follow-up records); 4. Patients for whom the type of laser hair removal device used is clearly specified (e.g., diode laser, long-pulse Nd:YAG laser, alexandrite laser, etc.).

Exclusion criteria

Exclusion criteria: 1. Presence of skin inflammation, pigmentation abnormalities, or other skin issues in the expanded flap area; 2. Concurrent systemic diseases that affect hair growth or skin healing (e.g., severe endocrine disorders, active autoimmune diseases, coagulation dysfunction); 3. Active infection, ulceration, or a history of radiation therapy in the expanded area; 4. Incomplete records of laser hair removal treatment (e.g., unclear parameters, number of sessions, or specific treatment sites); 5. Patients with missing follow-up data.

Design outcomes

Primary

MeasureTime frame
Patient satisfaction;Hair removal efficacy;Number of treatment sessions;

Countries

China

Contacts

Public ContactTang Xiaoqing

The First Affiliated Hospital of Army Medical University

617010089@qq.com+86 137 7805 1579

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026